Chow WA (2018) Chondrosarcoma: biology, genetics, and epigenetics [version 1; referees: 2 approved]. F1000Res 7(0). https://doi.org/10.12688/f1000research.15953.1

Ingangi V, De Chiara A, Ferrara G, Gallo M, Catapano A, Fazioli F et al (2024) Emerging treatments targeting the tumor microenvironment for advanced chondrosarcoma. Cells 13:977 Multidisciplinary Digital Publishing Institute (MDPI)

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zając AE, Kopeć S, Szostakowski B, Spałek MJ, Fiedorowicz M, Bylina E, Filipowicz P, Szumera-Ciećkiewicz A, Tysarowski A, Czarnecka AM, Rutkowski P (2021) Chondrosarcoma-from molecular pathology to novel therapies. Cancers 13(10):2390

Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H (2022) Therapeutic targets and emerging treatments in advanced chondrosarcoma. Int J Mol Sci 23:1096 MDPI

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amer KM, Munn M, Congiusta D, Abraham JA, Basu MA (2020) Survival and prognosis of chondrosarcoma subtypes: SEER database analysis. J Orthop Res 38(2):311–319

Article  PubMed  Google Scholar 

Fromm J, Klein A, Baur-Melnyk A, Knösel T, Lindner L, Birkenmaier C et al (2019) Survival and prognostic factors in conventional G1 chondrosarcoma. World J Surg Oncol 17(1):1–7

Article  Google Scholar 

Nota SPFT, Braun Y, Schwab JH, Van Dijk CN, Bramer JAM (2015) The identification of prognostic factors and survival statistics of conventional central chondrosarcoma. Sarcoma 2015:1

Article  Google Scholar 

Anderson ME (2016) Update on survival in osteosarcoma. Orthop Clin North Am [Internet] 47(1):283–92. https://doi.org/10.1016/j.ocl.2015.08.022

Article  PubMed  Google Scholar 

Nazeri E, GouranSavadkoohi M, Majidzadeh AK, Esmaeili R (2018) Chondrosarcoma: an overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets. Crit Rev Oncol/Hematol 131:102–109 Elsevier Ireland Ltd

Article  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell [Internet] 144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013

Article  PubMed  CAS  Google Scholar 

Howard R, Kanetsky PA, Egan KM (2019) Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep 9(1). https://doi.org/10.1038/s41598-019-56218-z

Garcia-Ortega DY, Ponce-Herrera D, Alvarez-Cano A, Caro-Sanchez C, Luna-Ortiz K (2022) Preoperative neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) as prognostic markers in patients with retroperitoneal liposarcoma. Surg Pract Sci 9:100076

Article  Google Scholar 

García-Ortega DY, Melendez-Fernandez AP, Alvarez-Cano A, Surgical Oncology Christus Muguerza Alta Especialidad Monterrey Nuevo Leon A, Clara-Altamirano MA, Luna-Ortiz K (2022) Neutrophil-to-lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma. https://doi.org/10.1016/j.suronc.2022.101746

Hu H, Huang X, Yang W, Wang S, Zeng Q, Li Y et al (2020) Potential value of pretreatment neutrophil-to-lymphocyte ratio in patients with bone sarcomas. https://doi.org/10.21203/rs.3.rs-16686/v1

Liu F, Luo H, Zhu Z, Zhu P, Huang J (2019) Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer. J Cell Physiol 234(12):22775–22786

Article  PubMed  CAS  Google Scholar 

Yapar A, Ulucaköy C, Sezgin EA, Atalay IB, Eksioglu MF (2020) Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma. Jt Dis Relat Surg 31(2):286–290

PubMed  PubMed Central  Google Scholar 

Liu C, Xing Y, Jiao Q, Yang Q, Yu W, Li Y et al (2020) Association of preoperative neutrophil/lymphocyte ratio with clinical outcomes in dedifferentiated chondrosarcoma patients. Cancer Manag Res 12:6719–6726

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu K, Li B, Huang Q, Jiang D, Sun H, Zhong N et al (2019) Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center. Eur Spine J 28(6):1468–1479

Article  PubMed  Google Scholar 

Weinschenk RC, Wang WL, Lewis VO (2021) Chondrosarcoma. J Am Acad Orthop Surg 29:553–62 Lippincott Williams and Wilkins

PubMed  Google Scholar 

Stevenson JD, Laitinen MK, Parry MC, Sumathi V, Grimer RJ, Jeys LM (2018) The role of surgical margins in chondrosarcoma. Eur J Surg Oncol 44(9):1412–1418

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network. Bone Cancer (Version 2.2024). http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf. Accessed 10 Jun 2024

Meijer D, de Jong D, Pansuriya TC, van den Akker BE, Picci P, Szuhai K et al (2012) Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer 51(10):899–909

Article  PubMed  CAS  Google Scholar 

Hirabayashi Y, Ishida T, Yoshida MA, Kojima T, Ehihara Y, Machinami R, Ikeuchi T (1995) Translocation (9; 22)(g22; ql2) A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 81(1):33–37

Verdegaal SHM, Bovée JVMG, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC et al (2011) Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist 16(12):1771–1779

Article  PubMed  PubMed Central  Google Scholar 

Liu B, Huang Y, Sun Y, Zhang J, Yao Y, Shen Z et al (2016) Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep 6(600):1–9

Google Scholar 

García-Ortega DY, Álvarez-Cano A, Sánchez-Llamas LA, Caro-Sanchez CHS, Martínez-Said H, Luna-Ortiz K et al (2018) Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma. Surg Oncol [Internet] 27(3):551–5. https://doi.org/10.1016/j.suronc.2018.07.012

Article  PubMed  Google Scholar 

Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG (2001) Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91(7):1201–1212

Article  PubMed  CAS  Google Scholar 

Thio QCBS, Goudriaan WA, Janssen SJ, Paulino Pereira NR, Sciubba DM, Rosovksy RP et al (2018) Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases. Br J Cancer [Internet] 119(6):737–43. https://doi.org/10.1038/s41416-018-0231-6

Article  PubMed  Google Scholar